Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heart Failure With Targeted Cancer Therapies
Virginia S. Hahn, Kathleen W. Zhang, Lova Sun, et al.
Circulation Research (2021) Vol. 128, Iss. 10, pp. 1576-1593
Open Access | Times Cited: 45

Showing 26-50 of 45 citing articles:

Major adverse cardiovascular events in advanced-stage lung cancer: a multicenter cohort study
Chih-Hao Chang, Shih-Hao Huang, Hung-Yu Huang, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 1
Use of heart failure medical therapy before and after a cancer diagnosis: A longitudinal study
Chengsheng Ju, Wallis C. Y. Lau, Charlotte Manisty, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 6, pp. 3911-3923
Open Access | Times Cited: 1
Zebrafish as an innovative model for exploring cardiovascular disease induction mechanisms and novel therapeutic interventions: a molecular insight
Shaukat Ali, Maryam Zulfiqar, Muhammad Summer, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
A recombinant fragment antigen-binding (Fab) of trastuzumab displays low cytotoxic profile in adult human cardiomyocytes: first evidence and the key implication of FcγRIIA receptor
Anna De Bartolo, Naomi Romeo, Alessandro Marrone, et al.
Acta Pharmacologica Sinica (2024)
Closed Access | Times Cited: 1
PATTERNS IN MORTALITY ASSOCIATED WITH HEART FAILURE AND LUNG CANCER AMONG OLDER ADULTS IN THE UNITED STATES: AN ANALYSIS OF 20 YEARS
Abdul Ahad, Eeshal Fatima, Wania Sultan, et al.
International Journal of Cardiology Cardiovascular Risk and Prevention (2024) Vol. 24, pp. 200353-200353
Open Access | Times Cited: 1
Using cultured canine cardiac slices to model the autophagic flux with doxorubicin
Asma Boukhalfa, Sally R. Robinson, Dawn M. Meola, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0282859-e0282859
Open Access | Times Cited: 3
Association of interleukin-10 rs1800896, rs1800872, and interleukin-6 rs1800795 polymorphisms with squamous cell carcinoma risk: A meta-analysis
Zhenxia Wei, Xiaoping Su, Qiurui Hu, et al.
Open Life Sciences (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Cancer therapeutics-related cardiovascular dysfunction: Basic mechanisms and clinical manifestation
Masayoshi Oikawa, Takafumi Ishida, Yasuchika Takeishi
Journal of Cardiology (2022) Vol. 81, Iss. 3, pp. 253-259
Open Access | Times Cited: 4
Cardiac computed tomography-derived extracellular volume fraction in the identification of cardiotoxicity: Another emerging imaging option
Thomas H. Schindler, Vijay Sharma, Anita Bhandiwad
IJC Heart & Vasculature (2021) Vol. 34, pp. 100806-100806
Open Access | Times Cited: 5
Mitigating Cardiotoxicity Associated with Anticancer Drugs: An Updated Systematic Review
Zobia Farooq, Rabeaa Sahar, Williams Chidozie Ibekwe, et al.
Journal of Cancer & Allied Specialties (2024) Vol. 10, Iss. 2
Open Access
Induction Chemotherapy‐Related Covert Cardiac Remodeling in Pre‐Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: A Retrospective Observational Study
Chang Dai, Weidong Lin, Fangzhou Liu, et al.
Cancer Medicine (2024) Vol. 13, Iss. 21
Open Access
Compensatory role of neuregulin-1 in diabetic cardiomyopathy
Yoshinori Mikami, Fumiki Iwase, Daisuke Ohshima, et al.
Journal of Pharmacological Sciences (2023) Vol. 153, Iss. 3, pp. 130-141
Open Access | Times Cited: 1
Heart Failure 2021
Douglas L. Mann
Circulation Research (2021) Vol. 128, Iss. 10, pp. 1419-1420
Closed Access | Times Cited: 3
Intracellular Cardiac Signaling Pathways Altered by Cancer Therapies
Shane S. Scott, Ashley Greenlee, Ethan Schwendeman, et al.
Springer eBooks (2022), pp. 111-173
Closed Access | Times Cited: 2
Seasonality of Deaths Due to Heart Diseases among Cancer Patients
Velizar Shivarov, Hristo Shivarov, Angel Yordanov
Medicina (2022) Vol. 58, Iss. 11, pp. 1651-1651
Open Access | Times Cited: 2
Kidney Response to Chemotherapy-Induced Heart Failure: mRNA Analysis in Normotensive and Ren-2 Transgenic Hypertensive Rats
Šárka Jíchová, Olga Gawryś, Elżbieta Kompanowska‐Jezierska, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8475-8475
Open Access | Times Cited: 2
Cardiotoxicity and pharmacogenetics of doxorubicin in black Zimbabwean breast cancer patients
Vincent Aketch Nyangwara, Tinashe Mazhindu, Zedias Chikwambi, et al.
Authorea (Authorea) (2022)
Open Access | Times Cited: 1
Oral Oncolytics and Cardiovascular Risk Management and Monitoring
Raechel T. White, Marie E. Sirek, Joel C. Marrs
Journal of Cardiovascular Pharmacology (2023) Vol. 82, Iss. 4, pp. 266-280
Closed Access
Kardiovaskuläre Überwachung und Primärprävention bei Krebstherapien
Hatim Seoudy, Derk Frank, Oliver J. Müller
Aktuelle Kardiologie (2023) Vol. 12, Iss. 04, pp. 272-278
Closed Access
Shared genetic architecture of Genitourinary Cancer and Heart Failure
Hai Jiang, Ming Cheng Liu, Cheng Xia, et al.
Research Square (Research Square) (2023)
Open Access
Previous Page - Page 2

Scroll to top